Therapeutic indications:

Seroquel XL® and Seroquel® (quetiapine) are indicated for:

  • Treatment of schizophrenia
  • Treatment of bipolar disorder:
    • For the treatment of moderate to severe manic episodes in bipolar disorder
    • For the treatment of major depressive episodes in bipolar disorder
    • For the prevention of recurrence of manic or depressed episodes in patients with Bipolar disorder who previously responded to quetiapine treatment.

Additionally, for Seroquel XL® only

  • Add-on treatment of major depressive episodes in patients with Major Depressive Disorder (MDD) who have had sub-optimal response to antidepressant monotherapy (see section 5.1 of SmPC). Prior to initiating treatment, clinicians should consider the safety profile of Seroquel XL (see section 4.4. of SmPC).
Adverse events should be reported

Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/.

Adverse events should also be reported to Luye Pharma Ltd. at safety@luyepharma.co.uk.

Seroquel XL® and Seroquel®

Technical information

Active Ingredients: Quetiapine fumarate
Therapeutic area: Mental health
Pharmaceutical Form: Tablets

Strengths, Pack size and Information

Description Strength Pack Size PIP Code
Seroquel 25mg 60 2440162
Seroquel 100mg 60 2440170
Seroquel 200mg 60 2440196
Seroquel 300mg 60 2981298
Seroquel XL 50mg 60 3343415
Seroquel XL 150mg 60 3577160
Seroquel XL 200mg 60 3343432
Seroquel XL 300mg 60 3343431
Seroquel XL 400mg 60 3343449